Pharma Partner — Publications

Resources and insights tagged pharma partner from Headwater.

Publications

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

Jazz Pharmaceuticals No

Real-world polypharmacy and healthcare resource utilization after early-line treatment with cannabidiol for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

Jazz Pharmaceuticals No

Real-World Dose Trajectory Patterns and Impact on Polypharmacy Burden and New Antiseizure Medication (ASM) Prescriptions in Patients With Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS), or Tuberous Sclerosis Complex (TSC) Receiving Cannabidiol (CBD)

Jazz Pharmaceuticals No

Real-World Effectiveness of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource Utilization: A US Claims Analysis.

GSK Emory University Amgen Inc.University of North Carolina at Chapel Hill Aarhus University Yes Regeneron Pharmaceuticals National Cheng Kung University Columbia University

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence

Publications

9

Total Publications

4

Abstract/Manuscript

1

Oral Presentation

4

Poster Presentation

2026 · Abstract/Manuscript · AbbVie

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi

Real-world polypharmacy and healthcare resource utilization after early-line treatment with cannabidiol for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi

Real-World Dose Trajectory Patterns and Impact on Polypharmacy Burden and New Antiseizure Medication (ASM) Prescriptions in Patients With Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS), or Tuberous Sclerosis Complex (TSC) Receiving Cannabidiol (CBD)

2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi

Real-World Effectiveness of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource Utilization: A US Claims Analysis.

2025 · Abstract/Manuscript · GSK

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence

2025 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi

Effect of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource Utilisation in Patients With Dravet Syndrome, Lennox-Gastaut Syndrome, or Tuberous Sclerosis Complex: Real-World Data from a US Claims Analysis

2024 · Abstract/Manuscript

Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review

2022 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi

Fracture Risk Estimation in Post-menopausal Women: A Comparison of Machine Learning Methods and Software Systems

Macro photograph of translucent oil bubbles on a vibrant orange and red gradient background, evoking scientific and biological imagery.

Contact us

By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.